FDA Device recall Z-0700-2018
MOOG Curlin Infusion Administration Set, Ref 340-4166, Non-DEHP Microbore Tubing with Non-Vented Spike, Anti-Siphon Valve included for Free…
- FDA Device
- Class II
- terminated
- Published 2018-03-07
On 2018-03-07 the FDA classified a Class II recall of MOOG Curlin Infusion Administration Set, Ref 340-4166, Non-DEHP Microbore Tubing with Non-Vented Spike, Anti-Siphon Valve included for Free… by Zevex Dba Moog Medical Medical Devices Group, citing particulate found on the Curlin spike.
Read the official FDA Device notice
| Agency | FDA Device |
|---|---|
| Recall number | Z-0700-2018 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2017-11-10 |
| Published | 2018-03-07 |
| Last updated | 2026-09-13 11:54 UTC |
| Company | Zevex Dba Moog Medical Medical Devices Group |
| Distribution | US |
Product
MOOG Curlin Infusion Administration Set, Ref 340-4166, Non-DEHP Microbore Tubing with Non-Vented Spike, Anti-Siphon Valve included for Free Flow Protection, packaged 20/box, for use with the Moog Curlin Ambulatory Volumetric Infusion Pump, RX, Sterile. Product Usage: Administration set to be used with the Moog Curlin infusion Pump. The pump can be used for intravenous, intra-arterial, epidural, subcutaneous, or enteral infusions.
Reason
Particulate found on the Curlin spike.
Identifiers
| code_info | UDI 38148440000563, Lot/serial numbers: CF1515305, CF1519505, CF1523004, CF1524405, CF1529201, CF1528602, CF1532105, CF…UDI 38148440000563, Lot/serial numbers: CF1515305, CF1519505, CF1523004, CF1524405, CF1529201, CF1528602, CF1532105, CF1601204, CF1604701, CF1605403, CF1609005, CF1609604, and CF1614732. |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:54 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0700-2018%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.